Compare GILT & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GILT | IRMD |
|---|---|---|
| Founded | 1987 | 1992 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1997 | 2014 |
| Metric | GILT | IRMD |
|---|---|---|
| Price | $15.61 | $91.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $19.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 868.4K | 107.7K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $15.06 | $12.38 |
| Revenue Next Year | $11.72 | $11.31 |
| P/E Ratio | ★ $42.82 | $206.78 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $5.46 | $51.26 |
| 52 Week High | $20.99 | $107.90 |
| Indicator | GILT | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 57.61 |
| Support Level | $13.38 | $82.87 |
| Resistance Level | $18.84 | $98.31 |
| Average True Range (ATR) | 1.11 | 2.87 |
| MACD | -0.38 | 1.18 |
| Stochastic Oscillator | 11.00 | 71.54 |
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.